Our results showed that RP11-295G20.2 inhibition indeed led to down-regulation of GRP78, providing evidence that RP11-295G20.2 knockdown alleviated ERS in LUAD cells. The gene discussed is HSPA5; the disease is amelogenesis imperfecta type 1G.